BioWorld Science

RSS

Bioway describes novel PI3Kdelta/PI3Kgamma inhibitors

Feb. 7, 2018

Lifesci Pharmaceuticals discloses new plasma kallikrein inhibitors

Feb. 7, 2018

Actinium to study Actimab-A with CLAG-M in relapsed or refractory AML

Feb. 7, 2018

Bavarian Nordic reports results from phase III pivotal study of smallpox vaccine

Feb. 7, 2018

Novel PAR-4 antagonists discovered at Bristol-Myers Squibb

Feb. 7, 2018

First patient treated in phase II study of Imprime PGG in combination with Keytruda

Feb. 7, 2018

Zogenix's ZX-008 granted FDA breakthrough therapy designation

Feb. 7, 2018

Servier and ImmunoQure to collaborate on the development of an interferon-alpha human autoantibody

Feb. 7, 2018

Topline data presented from phase II study of NGM-282 in primary sclerosing cholangitis

Feb. 7, 2018

Positive topline phase III results from ACHIEVE I study of ubrogepant

Feb. 7, 2018